Biopharm, Orquest, Sulzer Medica deal

By WIR Staff | Oct 4, 1999 | 7:00 AM GMT

Biopharm and Orquest will develop Healos/MP52, a bone growth factor

Read the full 109 word article

How to gain access

Continue reading with a
two-week free trial.